Lin Yan

Lin Yan


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 January 2026 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
EZErdi Zhang
Erdi Zhang
ZWZhengli Wan
Zhengli Wan
YMYuwen Ma
Yuwen Ma
YLYamei Li
Yamei Li
QZQixiang Zhou
Qixiang Zhou
LYLin Yan
Lin Yan
Introduction: Kidney transplantation is the preferred treatment for end-stage renal disease, but immune-mediated graft dysfunction remains a major barrier to long-term success. Conventional indicators such as serum creatinine and proteinuria are not immune-specific, and kidney biopsy is unsuitable for routine use. Mitochondrial function, a critical regulator of immune activation, may provide novel biomarkers for immune monitoring in transplantation. Methods: In this study, the percentage of peripheral immune cells with low mitochondrial membrane potential (MMP-Low%) and mitochondrial mass (MM) were assessed in 30 kidney transplant recipients and 44 healthy controls. Of the 30 transplant recipients, 15 provided paired samples before transplantation and at one month after transplantation with preserved graft function, while the other 15 had impaired graft function. Flow cytometry was used to measure lymphocyte subsets and mitochondrial parameters, which were further evaluated across specific T cell populations. Results: The results showed that increased age correlated with lower MMP-Low% and higher MM. Patients with impaired graft function showed significantly reduced MMP-Low% and elevated MM, suggesting enhanced metabolic activation, while those with preserved graft function displayed increased MMP-Low% and decreased MM, reflecting a quiescent metabolic profile consistent with immunosuppression. Discussion: These findings indicate that peripheral T cell mitochondrial metrics may serve as sensitive, dynamic, and non-invasive biomarkers for post-transplant immune monitoring.

8 September 2026 in Advanced Science
Verified
Journal Article
Open access
LYLin Yan
Lin Yan
EZErdi Zhang
Erdi Zhang
YMYuwen Ma
Yuwen Ma
ZMZirui Meng
Zirui Meng
SLSisi Li
Sisi Li
MWMinjin Wang
Minjin Wang
Anti‐ N‐methyl‐D‐aspartate receptor encephalitis (NMDAR‐E) is a prevalent autoimmune neurological disorder, yet T cell‐driven immunopathology and its contributions to therapeutic resistance and fulminant neuroinflammation remain poorly defined. Integrative single‐cell multi‐omic profiling, combining single‐cell RNA sequencing, single‐cell T cell receptor (TCR) sequencing, and cellular indexing of transcriptomes and epitopes by sequencing, is applied to systematically map peripheral and cerebrospinal fluid (CSF) immune landscapes in treatment‐naïve NMDAR‐E patients, with orthogonal validation conducted across independent cohorts via multiparameter flow cytometry and ex vivo NR1 peptide stimulation. Clonally expanded CX3CR1‐expressing CD4 + and CD8 + T cells are identified as a core disease‐associated effector population, characterized by high predicted affinity for the pathogenic GluN1 N368/G369 epitope, robust proinflammatory and cytotoxic transcriptional programs, and enhanced intercellular crosstalk with activated B cells through major histocompatibility complex (MHC), CD99, and macrophage migration inhibitory factor signaling axes. Preferentially enriched in patient CSF, these cells produce elevated interferon‐γ (IFN‐γ) and tumor necrosis factor‐α (TNF‐α) upon antigen‐specific stimulation, collectively highlighting a disease‐associated inflammatory T cell state linked to peripheral immune activation and CNS immune remodeling, with potential translational relevance for future biomarker and therapeutic investigation.

4 April 2026 in Immunobiology
Verified
Journal Article
Open access
BWBin Wei
Bin Wei
XDXinhua Dai
Xinhua Dai
EZErdi Zhang
Erdi Zhang
CLChuan Li
Chuan Li
JMJiansen Mao
Jiansen Mao
YLYi Li
Yi Li
There is currently no standardized model for assessing immune aging, which may contribute to the development and clinical progression of age-related diseases. We have developed an immune-age prediction model and conducted preliminary validation in patients. A total of 523 healthy adults were recruited for the establishment of the model. Additionally, 53 patients with hematological tumors, 38 patients who had experienced a stroke, and 105 patients with COVID-19 infection were enrolled as the validation cohort. Flow cytometric analysis was conducted to obtain results for 50 TBNK lymphocyte subsets. The proportion of patients exhibiting an immune age older than their actual age was 81.13% (43/53), 57.89% (22/38), and 65.71% (69/105) in individuals diagnosed with hematological tumors, stroke, and COVID-19 infection, respectively. In stroke patients with poor prognosis, the modified Rankin Scale (mRS) score at 90 days demonstrated a significant positive correlation with immune age (P < 0.01). The practical and convenient model demonstrated superior performance in assessing immunosenescence compared to chronological age. Our findings provide preliminary evidence linking early immune aging to adverse outcomes in stroke patients, suggesting its potential as a predictor that warrants further investigation in larger cohorts.

Verified
Open access
玉马玉雯 马
玉雯 马
EZErdi Zhang
Erdi Zhang
霖曹霖 曹
霖 曹
祉王祉茵 王
祉茵 王
旻王旻晋 王
旻晋 王
LYLin Yan
Lin Yan
探讨抗NMDAR脑炎(anti-N-methyl-D-aspartate receptor encephalitis, NMDAR-E)患者T淋巴细胞线粒体功能变化特征及其与免疫耗竭状态的相关性。 本研究纳入2025年1–3月在四川大学华西医院神经内科确诊的抗NMDAR脑炎患者25例(轻症14例,重症11例)及健康对照16名,采用流式细胞术检测患者外周血与脑脊液中免疫细胞分布,评估低线粒体膜电位细胞比例(low mitochondrial membrane potential, MMP-Low%)、线粒体质量(mitochondrial mass, MM)及PD-1表达水平。 重症患者脑脊液中CD3+和CD4+ T细胞占比、CD3+、CD4+和CD8+ T细胞的MMP-Low%以及CD3和CD8+ T细胞的MM均高于配对外周血(均P<0.05)。相比于健康对照,患者外周血CD4+和CD8+初始T细胞和中央记忆T细胞亚群MMP-Low%下降(P<0.05),同时CD4+初始T细胞和中央记忆T细胞亚群的PD-1阳性细胞比例上升(P<0.01)。 抗NMDAR脑炎患者脑脊液T细胞处于功能障碍性线粒体积聚状态,提示中枢炎症环境下T细胞线粒体质量稳态调控机制失衡。外周T细胞线粒体状态提示存在系统性免疫耗竭。脑脊液CD8+ T细胞MMP-Low%和外周血淋巴细胞占比可作为区分抗NMDAR-E脑炎患者病情轻重的潜在免疫代谢标志物。

31 July 2025 in BMC Microbiology
Verified
Journal Article
Open access
PDF file
YTYan-Xin Tao
Yan-Xin Tao
EZEr-Di Zhang
Er-Di Zhang
JYJia-Xi Yue
Jia-Xi Yue
ZWZheng-Li Wan
Zheng-Li Wan
JFJi-Wen Fan
Ji-Wen Fan
LYLin Yan
Lin Yan
Kidney transplantation is currently the most effective method for treating end-stage renal disease. However, postoperative-related rejection and IgA nephropathy remains a serious obstacle to the long-term survival of kidney transplant patients. Its pathogenesis is not fully understood, and potential causative factors remain to be explored. In this study, we used 2bRAD-M to analyze differences in the peripheral blood microbiome of renal transplant recipients who were stable postoperatively (STABLE) and those who developed chronic antibody-mediated rejection (CAMR) or IgA nephropathy (IgAN) recurrence. Thirty one renal transplant patients were recruited, including 12 STABLE, 8 CAMR and 11 IgAN patients after kidney transplantation. 2bRAD-M was used to characterize the microbiota in peripheral blood to explore the presence of microbial differences. Differences in microbial community composition were observed between CAMR, IgAN and STABLE. The alpha diversity of CAMR and IgAN was all higher than STABLE, there are also differences in beta diversity. LEfSe was performed to identify different abundance taxa, 21 discriminative features between CAMR and STABLE, 39 discriminative features between IgAN and STABLE. The mean decrease Gini index and random forest analysis indicated that Staphylococcus_epidermidis might serve as indicator bacteria for CAMR, Kocuria_palustris might serve as indicator bacteria for IgAN. ROC analysis was performed to assess the performance of some optimal marker models, and the average AUC value achieved 89.6% between CAMR and STABLE, 67.4% between IgAN and STABLE. Functional annotation analysis showed 4353 different COGs and 378 related signaling pathways between CAMR and STABLE, 4396 different COGs and 384 related signaling pathways between CAMR and STABLE. The first 2bRAD-M microbiome study of CAMR and IgAN after renal transplantation showed a potential association between the circulating microbiome and the disease, and provided a possible target and basis for subsequent studies of the mechanisms underlying the development and progression of CAMR and IgAN after renal transplantation.